Wearing-off detection in clinical practice: The wearing off real practice key (WORK-PD) study in Parkinson's disease

M. C. Altavista, E. Cassetta, L. Brusa, F. Viselli, A. Denaro, M. Ventriglia, P. Pasqualetti, A. Peppe

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Objective: Verifying the validity and feasibility of the WOQ-19 as a useful tool in routine clinical practice and in management of patients. Methods: 532 consecutive Parkinson's disease (PD) patients were recruited from 6 different neurological outpatient units, specialized in movement disorders, of central Italy. Inclusion criteria were diagnosis of PD and any current pharmacological treatment of PD while exclusion criteria were evident cognitive or depressive impairment, infusion with dopamine agonists or Duodopa, or Deep Brain Stimulation therapy. Patients were asked to complete the Italian version of WOQ-19 before the neurological visit. A medical form for the collection of demographic and clinical data of patients and for the evaluation of comprehensibility and usability the WOQ-19 was filled by the neurologist during the visit. Results: Our data confirmed that WOQ-19 was able to identify WO in 69% of patients, a percentage similar to the recently reported in the Italian WOQ-19 validation study. Motor symptoms were more frequent than non-motor symptoms (80% vs. 20%). Patients who experienced WO had a higher age of PD onset, more severe disease, longer disease duration and were more likely to be female. Conclusions: The WOQ-19 was understandable for the patient, easily administered and suitable for routine outpatient use. It could be also particularly useful in clinical practice in the early identification of non-motor symptoms, often under reported by patients and revealed only with clinical support.

Original languageEnglish
Pages (from-to)95-100
Number of pages6
JournalParkinsonism and Related Disorders
Volume21
Issue number2
DOIs
Publication statusPublished - Feb 1 2015

Fingerprint

Parkinson Disease
Outpatients
Deep Brain Stimulation
Validation Studies
Practice Management
Dopamine Agonists
Movement Disorders
Italy
Demography
Pharmacology
Therapeutics

Keywords

  • Parkinson's disease
  • Wearing-off
  • WOQ-19 questionnaire

ASJC Scopus subject areas

  • Geriatrics and Gerontology
  • Clinical Neurology
  • Neurology
  • Medicine(all)

Cite this

Wearing-off detection in clinical practice : The wearing off real practice key (WORK-PD) study in Parkinson's disease. / Altavista, M. C.; Cassetta, E.; Brusa, L.; Viselli, F.; Denaro, A.; Ventriglia, M.; Pasqualetti, P.; Peppe, A.

In: Parkinsonism and Related Disorders, Vol. 21, No. 2, 01.02.2015, p. 95-100.

Research output: Contribution to journalArticle

Altavista, M. C. ; Cassetta, E. ; Brusa, L. ; Viselli, F. ; Denaro, A. ; Ventriglia, M. ; Pasqualetti, P. ; Peppe, A. / Wearing-off detection in clinical practice : The wearing off real practice key (WORK-PD) study in Parkinson's disease. In: Parkinsonism and Related Disorders. 2015 ; Vol. 21, No. 2. pp. 95-100.
@article{16a6a00ef1894103b6c25463237f5b2a,
title = "Wearing-off detection in clinical practice: The wearing off real practice key (WORK-PD) study in Parkinson's disease",
abstract = "Objective: Verifying the validity and feasibility of the WOQ-19 as a useful tool in routine clinical practice and in management of patients. Methods: 532 consecutive Parkinson's disease (PD) patients were recruited from 6 different neurological outpatient units, specialized in movement disorders, of central Italy. Inclusion criteria were diagnosis of PD and any current pharmacological treatment of PD while exclusion criteria were evident cognitive or depressive impairment, infusion with dopamine agonists or Duodopa, or Deep Brain Stimulation therapy. Patients were asked to complete the Italian version of WOQ-19 before the neurological visit. A medical form for the collection of demographic and clinical data of patients and for the evaluation of comprehensibility and usability the WOQ-19 was filled by the neurologist during the visit. Results: Our data confirmed that WOQ-19 was able to identify WO in 69{\%} of patients, a percentage similar to the recently reported in the Italian WOQ-19 validation study. Motor symptoms were more frequent than non-motor symptoms (80{\%} vs. 20{\%}). Patients who experienced WO had a higher age of PD onset, more severe disease, longer disease duration and were more likely to be female. Conclusions: The WOQ-19 was understandable for the patient, easily administered and suitable for routine outpatient use. It could be also particularly useful in clinical practice in the early identification of non-motor symptoms, often under reported by patients and revealed only with clinical support.",
keywords = "Parkinson's disease, Wearing-off, WOQ-19 questionnaire",
author = "Altavista, {M. C.} and E. Cassetta and L. Brusa and F. Viselli and A. Denaro and M. Ventriglia and P. Pasqualetti and A. Peppe",
year = "2015",
month = "2",
day = "1",
doi = "10.1016/j.parkreldis.2014.11.002",
language = "English",
volume = "21",
pages = "95--100",
journal = "Parkinsonism and Related Disorders",
issn = "1353-8020",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - Wearing-off detection in clinical practice

T2 - The wearing off real practice key (WORK-PD) study in Parkinson's disease

AU - Altavista, M. C.

AU - Cassetta, E.

AU - Brusa, L.

AU - Viselli, F.

AU - Denaro, A.

AU - Ventriglia, M.

AU - Pasqualetti, P.

AU - Peppe, A.

PY - 2015/2/1

Y1 - 2015/2/1

N2 - Objective: Verifying the validity and feasibility of the WOQ-19 as a useful tool in routine clinical practice and in management of patients. Methods: 532 consecutive Parkinson's disease (PD) patients were recruited from 6 different neurological outpatient units, specialized in movement disorders, of central Italy. Inclusion criteria were diagnosis of PD and any current pharmacological treatment of PD while exclusion criteria were evident cognitive or depressive impairment, infusion with dopamine agonists or Duodopa, or Deep Brain Stimulation therapy. Patients were asked to complete the Italian version of WOQ-19 before the neurological visit. A medical form for the collection of demographic and clinical data of patients and for the evaluation of comprehensibility and usability the WOQ-19 was filled by the neurologist during the visit. Results: Our data confirmed that WOQ-19 was able to identify WO in 69% of patients, a percentage similar to the recently reported in the Italian WOQ-19 validation study. Motor symptoms were more frequent than non-motor symptoms (80% vs. 20%). Patients who experienced WO had a higher age of PD onset, more severe disease, longer disease duration and were more likely to be female. Conclusions: The WOQ-19 was understandable for the patient, easily administered and suitable for routine outpatient use. It could be also particularly useful in clinical practice in the early identification of non-motor symptoms, often under reported by patients and revealed only with clinical support.

AB - Objective: Verifying the validity and feasibility of the WOQ-19 as a useful tool in routine clinical practice and in management of patients. Methods: 532 consecutive Parkinson's disease (PD) patients were recruited from 6 different neurological outpatient units, specialized in movement disorders, of central Italy. Inclusion criteria were diagnosis of PD and any current pharmacological treatment of PD while exclusion criteria were evident cognitive or depressive impairment, infusion with dopamine agonists or Duodopa, or Deep Brain Stimulation therapy. Patients were asked to complete the Italian version of WOQ-19 before the neurological visit. A medical form for the collection of demographic and clinical data of patients and for the evaluation of comprehensibility and usability the WOQ-19 was filled by the neurologist during the visit. Results: Our data confirmed that WOQ-19 was able to identify WO in 69% of patients, a percentage similar to the recently reported in the Italian WOQ-19 validation study. Motor symptoms were more frequent than non-motor symptoms (80% vs. 20%). Patients who experienced WO had a higher age of PD onset, more severe disease, longer disease duration and were more likely to be female. Conclusions: The WOQ-19 was understandable for the patient, easily administered and suitable for routine outpatient use. It could be also particularly useful in clinical practice in the early identification of non-motor symptoms, often under reported by patients and revealed only with clinical support.

KW - Parkinson's disease

KW - Wearing-off

KW - WOQ-19 questionnaire

UR - http://www.scopus.com/inward/record.url?scp=84921363151&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921363151&partnerID=8YFLogxK

U2 - 10.1016/j.parkreldis.2014.11.002

DO - 10.1016/j.parkreldis.2014.11.002

M3 - Article

C2 - 25443558

AN - SCOPUS:84921363151

VL - 21

SP - 95

EP - 100

JO - Parkinsonism and Related Disorders

JF - Parkinsonism and Related Disorders

SN - 1353-8020

IS - 2

ER -